Bone Therapeutics to present data from its Phase II/III trial with JTA-004 at the 2nd World Congress on Rheumatology & Orthopedics
Gosselies, Belgium, 27 September 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address high unmet medical needs in orthopaedics and bone diseases, announces that Dr. Olivier Godeaux, Chief Medical Officer of Bone Therapeutics, will give a keynote presentation at the 2nd World Congress on Rheumatology & Orthopedics (WCRO) in Paris, France, today at 10:45am CEST.
WCRO serves as an international platform to bring prominent speakers, renowned scientists, professors, deans, surgeons, physicians, medical and industrial professionals, and business delegates together to exchange new insights and to share recent progress in the field of rheumatology and orthopaedics. The event is supported by 20 orthopaedic societies in Europe, America and Asia and is expected to receive participants and experts from over 40 countries across the globe.
The oral presentation will discuss the results from the Phase II/III study with JTA-004, Bone Therapeutics’ novel enriched protein solution, currently in development for the treatment of osteoarthritis of the knee.
Title: Safety and efficacy of intra-articular injection of JTA-004, a novel supplemented protein solution, in symptomatic knee osteoarthritis: a randomized, double-blind controlled phase II/III study
Authors: Marie Bettonville1, Anne-Sophie Delmarcelle1, Marc Léon2, Bogdan Ster3, Jean-François Kaux4, Thierry Appelboom5, Joëlle Margaux6, Didier Urbin-Choffray7, Emilie Theunissen8, Tatiana Besse-Hammer9, Philippe De Greift10, Jiangang Qu11, Yves Fortems12, Séverine Verlinden13, and Olivier Godeaux1
Date: Friday, 27 September 2019
Time: 10:45 – 11:15am CEST
Location: Main Hall, Holiday Inn Paris - Porte de Clichy, France
1Bone Therapeutics S.A., Belgium; 2CHU Ambroise Paré, Belgium; 3CHU Saint-Pierre, Belgium; 4University and University Hospital of Liège, Belgium; 5Hôpitaux Iris Sud Molière Longchamp, Belgium; 6CUB Erasme, Belgium; 7CHR Citadelle, Belgium; 8Clinique Saint-Pierre Ottignies, Belgium; 9CHU Brugmann, Belgium; 10CHR de Namur, Belgium; 11Hôpitaux Iris Sud Etterbeek-Ixelles, Belgium; 12AZ Sint Jozef, Belgium; 13CHR Haute Senne, Belgium.